Arginine reprograms metabolism in liver cancer via RBM39
2023 · Cell · 237 citations
https://doi.org/10.1016/j.cell.2023.09.011
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
10
Papers
351
Citations
4
h-index
4
i10-index
Brendan M Ryback is an academic researcher from Metabolic Technologies (United States). The author has contributed to research in topics: Cancer, Hypoxia, and Metabolism & Gene Regulatory Network Analysis & Bioinformatics and Genomic Networks. The author has an h-index of 4, co-authored 9 publications.
Click to start Chat